• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用铟 - 111标记的双功能半抗原对小鼠肿瘤进行预靶向免疫闪烁显像。

Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.

作者信息

Goodwin D A, Meares C F, McCall M J, McTigue M, Chaovapong W

机构信息

Nuclear Medicine Service, Veterans Administration Medical Center, Palo Alto, CA 94304.

出版信息

J Nucl Med. 1988 Feb;29(2):226-34.

PMID:3346734
Abstract

A method of tumor imaging utilizing the nonspecific accumulation of antibody through leaky capillaries is described, in which the antibody and the radiolabel are administered separately. Nonradioactive antibody is given first (pre-targeted), and allowed adequate time to reach maximum tumor concentration. Depending on the antibody, this may take several days. At the time of maximum tumor concentration of nonradioactive antibody, the blood is quickly cleared of excess circulating nonradioactive antibody using a special i.v. "chase". The radiolabel then is given and imaging done in 1 to 3 hr. The use of short lived tracers (hours) to image antibodies that localize slowly (days) in-vivo is made possible by this method.

摘要

描述了一种利用抗体通过渗漏毛细血管的非特异性聚集进行肿瘤成像的方法,其中抗体和放射性标记物分别给药。首先给予非放射性抗体(预靶向),并给予足够时间以达到最大肿瘤浓度。根据抗体的不同,这可能需要几天时间。在非放射性抗体达到最大肿瘤浓度时,使用特殊的静脉“追踪”快速清除血液中多余的循环非放射性抗体。然后给予放射性标记物,并在1至3小时内进行成像。通过这种方法,可以使用短寿命示踪剂(数小时)对在体内缓慢定位(数天)的抗体进行成像。

相似文献

1
Pre-targeted immunoscintigraphy of murine tumors with indium-111-labeled bifunctional haptens.用铟 - 111标记的双功能半抗原对小鼠肿瘤进行预靶向免疫闪烁显像。
J Nucl Med. 1988 Feb;29(2):226-34.
2
Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.
J Nucl Med. 1992 Nov;33(11):2006-13.
3
Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.双特异性单克隆抗体偶联物介导的铟111标记二价半抗原靶向人黑色素瘤:裸鼠体内肿瘤的成像
Cancer Res. 1990 Jun 1;50(11):3445-52.
4
Differences in experimental tumor localization of dual-labeled monoclonal antibody.
J Nucl Med. 1986 Aug;27(8):1293-9.
5
67Ga-labeled antibodies for immunoscintigraphy and evaluation of tumor targeting of drug-antibody conjugates in mice.
Cancer Res. 1988 Mar 1;48(5):1189-94.
6
Pharmacokinetics, biodistribution, and gamma camera imaging of 111In-KC-4G3 murine monoclonal antibody in athymic nude mice with or without human tumor xenografts.111In-KC-4G3鼠单克隆抗体在有或无人肿瘤异种移植的无胸腺裸鼠中的药代动力学、生物分布及γ相机显像
Cancer Res. 1990 Sep 15;50(18):5954-61.
7
Dynamic interaction of 111indium-labeled monoclonal antibodies with surface antigens of solid tumors visualized in vivo by external scintigraphy.
J Natl Cancer Inst. 1986 May;76(5):849-55.
8
Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.双特异性抗体介导的放射性标记二价半抗原靶向:理论、实验及临床结果
Int J Cancer Suppl. 1992;7:58-62.
9
Hyperthermia enhances localization of 111In-labeled hapten to bifunctional antibody in human colon tumor xenografts.热疗增强了111铟标记的半抗原在人结肠肿瘤异种移植模型中与双功能抗体的结合。
Cancer Res. 1991 Mar 1;51(5):1515-20.
10
Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.双特异性单克隆抗体介导的铟-111标记的二乙三胺五乙酸二聚体靶向原发性结直肠癌肿瘤:药代动力学、生物分布、闪烁扫描及免疫反应。
J Nucl Med. 1993 Oct;34(10):1662-71.

引用本文的文献

1
Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies.减少放射性标记抗体对正常组织辐射的方法。
Pharmaceuticals (Basel). 2024 Apr 16;17(4):508. doi: 10.3390/ph17040508.
2
Development of a 99mTc-labeled tetrazine for pretargeted SPECT imaging using an alendronic acid-based bone targeting model.基于阿仑膦酸的骨靶向模型制备 99mTc 标记的四嗪用于前靶向 SPECT 成像。
PLoS One. 2024 Apr 16;19(4):e0300466. doi: 10.1371/journal.pone.0300466. eCollection 2024.
3
Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin's lymphoma.
非霍奇金淋巴瘤放射免疫疗法的近期临床前和临床进展。
Explor Target Antitumor Ther. 2024;5(1):208-224. doi: 10.37349/etat.2024.00213. Epub 2024 Feb 28.
4
Clearing and Masking Agents in Pretargeting Strategies.预靶向策略中的清除和掩蔽剂
Pharmaceuticals (Basel). 2023 Mar 27;16(4):497. doi: 10.3390/ph16040497.
5
Pretargeting: A Path Forward for Radioimmunotherapy.前靶向:放射免疫治疗的一个前进方向。
J Nucl Med. 2022 Sep;63(9):1302-1315. doi: 10.2967/jnumed.121.262186.
6
Evaluation of an antibody-PNA conjugate as a clearing agent for antibody-based PNA-mediated radionuclide pretargeting.评估抗体 - PNA 缀合物作为基于抗体的 PNA 介导放射性核素前靶向的清除剂。
Sci Rep. 2020 Nov 27;10(1):20777. doi: 10.1038/s41598-020-77523-y.
7
Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update.用于肿瘤疾病成像的抗体免疫正电子发射断层显像/单光子发射计算机断层显像放射性药物的进展——最新情况
Cancers (Basel). 2020 Jul 11;12(7):1868. doi: 10.3390/cancers12071868.
8
Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept.使用生物正交点击化学进行腹膜癌病的靶向放射性免疫治疗和 SPECT 成像:探针选择和初步概念验证。
Theranostics. 2019 Sep 19;9(22):6706-6718. doi: 10.7150/thno.35461. eCollection 2019.
9
The Future of Bioorthogonal Chemistry.生物正交化学的未来。
ACS Cent Sci. 2018 Aug 22;4(8):952-959. doi: 10.1021/acscentsci.8b00251. Epub 2018 Jul 23.
10
Evaluation of a Pretargeting Strategy for Molecular Imaging of the Prostate Stem Cell Antigen with a Single Chain Antibody.评价一种利用单链抗体对前列腺干细胞抗原进行分子成像的前靶向策略。
Sci Rep. 2018 Feb 28;8(1):3755. doi: 10.1038/s41598-018-22179-y.